- Home
- KIDS vs CION Comparison
KIDS vs CION Comparison
Compare KIDS & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- CION
- Stock Information
- Founded
- KIDS 2007
- CION 2011
- Country
- KIDS United States
- CION United States
- Employees
- KIDS N/A
- CION N/A
- Industry
- KIDS Medical/Dental Instruments
- CION Finance/Investors Services
- Sector
- KIDS Health Care
- CION Finance
- Exchange
- KIDS Nasdaq
- CION Nasdaq
- Market Cap
- KIDS 530.8M
- CION 517.0M
- IPO Year
- KIDS 2017
- CION N/A
- Fundamental
- Price
- KIDS $21.89
- CION $9.84
- Analyst Decision
- KIDS Buy
- CION Sell
- Analyst Count
- KIDS 7
- CION 2
- Target Price
- KIDS $35.71
- CION $11.00
- AVG Volume (30 Days)
- KIDS 128.7K
- CION 354.1K
- Earning Date
- KIDS 08-04-2025
- CION 08-07-2025
- Dividend Yield
- KIDS N/A
- CION 14.71%
- EPS Growth
- KIDS N/A
- CION N/A
- EPS
- KIDS N/A
- CION N/A
- Revenue
- KIDS $212,453,000.00
- CION $234,952,000.00
- Revenue This Year
- KIDS $19.23
- CION N/A
- Revenue Next Year
- KIDS $17.14
- CION N/A
- P/E Ratio
- KIDS N/A
- CION N/A
- Revenue Growth
- KIDS 31.28
- CION N/A
- 52 Week Low
- KIDS $19.52
- CION $8.51
- 52 Week High
- KIDS $35.99
- CION $12.71
- Technical
- Relative Strength Index (RSI)
- KIDS 52.66
- CION 62.89
- Support Level
- KIDS $21.17
- CION $9.61
- Resistance Level
- KIDS $22.76
- CION $9.89
- Average True Range (ATR)
- KIDS 0.81
- CION 0.16
- MACD
- KIDS 0.09
- CION 0.05
- Stochastic Oscillator
- KIDS 70.00
- CION 92.67
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About CION CION Investment Corporation
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.